Safer insulin prescribing - Fact sheet
This factsheet outlines the critical safety elements for safer insulin prescribing within the context of active ingredient prescribing. As prescriptions are generated with the active ingredient name, prescribers should check the brand name is included. Inclusion of insulin brand name supports safer product identification and selection.
Downloads
Safer insulin prescribing - Fact sheet
- Publication Year:
- 2022
- Resource Type:
- Fact sheet
Accessibility: We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright: Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by emailing our Communications team.